{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:59:38Z","timestamp":1785387578175,"version":"3.55.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Axillary lymph node dissection (ALND) has been standard for regional control in clinically node-positive breast cancer, but causes significant morbidity, including lymphedema and arm dysfunction. Targeted axillary dissection (TAD) is a less invasive alternative after neoadjuvant systemic therapy (NST), which can downstage nodal disease. Emerging evidence suggests that TAD offers oncologic outcomes similar to ALND with less morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients with clinically node-positive (cN1) breast cancer treated between 2017 and 2025 at the Montefiore Einstein Breast Care Center who received NST followed by surgery. Patients were categorized based on axillary surgical procedure (TAD or ALND) and evaluated for oncologic and morbidity outcomes. Axillary procedure selection was based on both clinical staging and response to neoadjuvant therapy. Morbidity endpoints include lymphedema, upper extremity functional impairment or range of motion limitations, compression sleeve use, rehabilitation referral, and changes in L-Dex scores. Lymphedema was diagnosed by comparing preoperative and postoperative L-Dex scores, with a change of six or more indicating diagnosis. Patient data were collected for a mean follow-up of four years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 256 patients, 136 (53.1%) underwent TAD, 14 SLNB (5.5%), and 106 ALND (41.4%). ALND had higher clinical tumor stages (p = 0.042) and a larger number of nodes removed (4.5 vs 15.3, p &amp;lt; 0.001). Pathologic complete response (pCR) and axillary complete response rates were higher with TAD (pCR:46% vs. 10.4%, p &amp;lt; 0.001; axillary CR: 64% vs. 12.3%). ALND was associated with higher rates of lymphedema (27.4% vs. 12.7%, p = 0.002), upper-extremity impairment (33.9% vs. 18%, p &amp;lt; 0.001), and rehabilitation referral (39.6% vs. 21.3%, p = 0.005). ALND led to a higher mean postoperative L-Dex score change (5.5 vs. 3.2; p = 0.042), reflecting greater lymphatic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In cN1 patients treated with NST, TAD was associated with significantly lower rates of lymphedema and upper extremity morbidity compared to ALND, while also demonstrating higher pathologic and axillary complete response rates. These key findings emphasize the benefit of selective axillary de-escalation with TAD, supporting its role in reducing treatment-related morbidity while maintaining oncologic safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1820926","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:52Z","timestamp":1785385312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["De-escalating the axilla: oncologic and morbidity outcomes of targeted axillary dissection versus axillary lymph node dissection following neoadjuvant systemic therapy in clinically node-positive breast cancer within a single institution"],"prefix":"10.3389","volume":"16","author":[{"given":"Skylar","family":"Harbour","sequence":"first","affiliation":[{"name":"Albert Einstein College of Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ki","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Montefiore Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Chen","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Dai","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Montefiore Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Ravetch","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Montefiore Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Samson","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Montefiore Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"McEvoy","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Montefiore Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.04.088","article-title":"Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies","volume":"125","author":"Wang","year":"2020","journal-title":"Br J Anaesth"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1053-4296(03)00038-9","article-title":"The grading of lymphedema in oncology clinical trials","volume":"13","author":"Cheville","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2021.0033","article-title":"Lymphedema after axillary lymph node dissection in breast cancer: prevalence and risk factors-a single-center retrospective study","volume":"20","author":"Hara","year":"2022","journal-title":"Lymphat Res Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27467","article-title":"Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care","volume":"118","author":"Hayes","year":"2012","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4683-0","article-title":"A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema","volume":"22","author":"Barrio","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17301-0","article-title":"Long-term outcomes of lymphedema after immediate lymphatic reconstruction following axillary lymph node dissection","volume":"32","author":"Hassan","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005671","article-title":"Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis","volume":"277","author":"Che Bakri","year":"2023","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00520-022-07508-2","article-title":"Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies","volume":"31","author":"Shen","year":"2022","journal-title":"Support Care Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34377","article-title":"Risk factors for breast cancer-related lymphedema in patients undergoing 3\u2009years of prospective surveillance with intervention","volume":"128","author":"Koelmeyer","year":"2022","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.12311","article-title":"Role of sonography for the locoregional staging of breast cancer","volume":"203","author":"Lane","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2414859","article-title":"Omitting regional nodal irradiation after response to neoadjuvant chemotherapy","volume":"392","author":"Mamounas","year":"2025","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-16143-6","article-title":"Omission of axillary lymph node dissection in patients with residual nodal disease after neoadjuvant chemotherapy","volume":"31","author":"Limberg","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-16973-y","article-title":"Oncologic outcomes with de-escalation of axillary surgery after neoadjuvant chemotherapy for breast cancer: results from > 1500 patients on the I-SPY2 clinical trial","volume":"32","author":"Boughey","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08902-y","article-title":"Node-positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers","volume":"27","author":"Laws","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"P2","DOI":"10.1158\/1557-3265.SABCS24-P2-03-14","article-title":"Abstract P2-03-14: Patient reported outcomes and lymphedema in node positive breast cancer in the early postoperative period after neoadjuvant chemotherapy in the prospective Neosentiturk- trail MF18-03","volume":"31","author":"Cabioglu","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"B25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.breast.2022.02.013","article-title":"Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial","volume":"63","author":"Appelgren","year":"2022","journal-title":"Breast"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla \u2013 surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt P\u00e9ley","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2015.01.006","article-title":"Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review","volume":"96","author":"De Groef","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1742","article-title":"Factors associated with lymphedema in women with node-positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection","volume":"154","author":"Armer","year":"2019","journal-title":"JAMA Surg"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0168","article-title":"The epidemiology of arm and hand swelling in premenopausal breast cancer survivors","volume":"16","author":"Paskett","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3201","article-title":"Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011","volume":"22","author":"Fu","year":"2013","journal-title":"Psychooncology"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1820926\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:21:53Z","timestamp":1785385313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1820926\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":31,"alternative-id":["10.3389\/fonc.2026.1820926"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1820926","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1820926"}}